Publication | Closed Access

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases

Bone DiseaseBone Turnover MarkersBody CompositionBone HealthHealth SciencesFracture DiagnosticsBone DensityMedicineOsteoporosisBone MetabolismJapanese SubjectsHigh Risk